Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metastasis suppressor pathways--an evolving paradigm.

Lalita A Shevde1, Danny R Welch

  • 1Department of Pathology, 1670 University Boulevard, Volker Hall-G-038, The University of Alabama at Birmingham, Birmingham, AL 35294-0019, USA.

Cancer Letters
|August 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An in vitro hydrogel-based model to study dormancy associated drug resistance in metastatic breast cancer spheroids.

npj biomedical innovations·2026
Same author

TRMT112 drives a tumor growth and metastasis-promoting program in triple-negative breast cancer.

Cell death and differentiation·2026
Same author

Flipping the narrative on launching a rewarding career in academic medicine.

Nature cancer·2025
Same author

Strain Promotes Triple Negative Breast Cancer Proliferation and Migration Via VEGFR-2.

Cellular and molecular bioengineering·2025
Same author

BioBridge Prepares Students to Successfully Bridge into High School Biology Through Cancer Research Education.

Journal of STEM outreach·2025
Same author

Glucocorticoid Receptor Signaling Mediates Resistance to Therapy in Matrix Rigidity-Induced Dormant Brain Metastatic Breast Cancer Spheroids.

ACS biomaterials science & engineering·2025
Same journal

Stress-adapted cancer-associated fibroblasts as mediators of immunosuppression and therapy resistance.

Cancer letters·2026
Same journal

Aldo-keto Reductase Family 1 Member C3 Suppresses Glioma Progression via Inhibiting Prostaglandin D2-Dependent RhoA/ROCK Signaling.

Cancer letters·2026
Same journal

Immunotherapy-based combination remodels the immunosuppressive microenvironment and enhances efficacy in advanced SMARCA4-deficient non-small cell lung cancer.

Cancer letters·2026
Same journal

Early-onset lung cancer: etiologic heterogeneity, genomic features, and age-informed clinical management.

Cancer letters·2026
Same journal

Talazoparib engages innate immune activation via PARP trapping-dependent cGAS/STING activation in Ewing Sarcoma.

Cancer letters·2026
Same journal

Corrigendum to "Elevated MMP10/13 mediated barrier disruption and NF-κB activation aggravate colitis and colon tumorigenesis in both individual or full miR-148/152 family knockout mice" [Cancer Lett. (2022) 31 529 53-69].

Cancer letters·2026
See all related articles

Understanding metastasis suppressor genes is key to fighting cancer deaths. This review details known genes and promising new candidates, aiding the development of novel cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tumor invasion and metastasis are the primary causes of cancer mortality.
  • Metastasis suppressor genes offer potential therapeutic targets as they inhibit metastasis without affecting tumor growth.
  • Identifying and understanding these genes is crucial for developing new cancer treatments.

Purpose of the Study:

  • To review known metastasis suppressor genes with existing functional data.
  • To highlight newly identified genes with potential metastasis suppressor activity.
  • To summarize mechanisms of action and propose pathways involved in metastasis suppression.

Main Methods:

  • Literature review of functional data on metastasis suppressor genes.
  • Identification and preliminary assessment of novel candidate genes.

Related Experiment Videos

  • Synthesis of biochemical mechanisms and pathway assembly.

    • Main Results:

    • Detailed review of twelve metastasis suppressor genes with established functional data.
    • Introduction of several promising new genes requiring further functional validation.
    • Summary of known biochemical mechanisms and a proposed model for metastasis suppression pathways.

    Conclusions:

    • Metastasis suppressor genes are critical targets for novel cancer therapies.
    • Continued research into both established and novel metastasis suppressor genes will advance our understanding of cancer progression.
    • Elucidating metastasis suppression pathways can lead to more effective prognostic and therapeutic strategies.